Basel Medical BMGL Income Statement (2024-2026)

NASDAQ BMGL
$0.68 -1.25 (-64.56%)
At close: Nov 11, 2026 · 4:00 PM EST
Reported Financials

Basel Medical Quarterly Income Statement

Periods 5 quarters
Latest Jun 2026

Basel Medical income statement data for the quarter ended Jun 2026. This income statement covers 5 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Jun2024 Dec2024 Jun2025 Dec2025 Jun2026
Operating items
Operating ExpensesOpex -0.12M0.00M
Non-operating items
Non Operating Interest Expenses -0.10M-0.22M
Gains (Losses) on Sale of Assets & InvestmentsGains on Sales -0.33M
Other Non Operating IncomeOther Non Op Inc. 2.11M
Net income details
Tax ProvisionsTaxes -388.00-0.18M
Additional items
Shares Outstanding 1.35M1.35M1.57M1.57M1.58M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 1.35M1.35M1.57M1.57M1.58M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 1.35M1.57M1.58M
Interest ExpensesInt Expense -0.10M-0.22M

Basel Medical Income Statement API

Pull Basel Medical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BMGL&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY